Elimination Kinetics of Amsacrine in the Rabbit: Evidence of Nonlinearity
- 1 January 1985
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 31 (1) , 50-56
- https://doi.org/10.1159/000138097
Abstract
Plasma amsacrine [an antitumor drug] kinetics were studied in rabbits after different doses (2.5-10 mg/kg) infused over 35 min. Amsacrine concentrations were measured by HPLC [high-performance liquid chromatography] and plasma protein binding by equilibrium dialysis. All elimination curves were best fitted by a bi-exponential expression with a mean t1/2.alpha. [.alpha.-phase half-life] of 0.56 h and t1/2.beta. of 2.47 h. At doses > 5 mg/kg, there appeared to be an overproportional increase in the area under the curve, suggesting nonlinear kinetics. Comparison of pharmacokinetic parameters indicated a significant decrease in plasma Cl after the 10-mg/kg dose compared to the 5- and 2.5-mg/kg dose. Amsacrine was highly bound by plasma (96.8%) over the concentration range 1-100 .mu.mol/l. The rabbit is evidently an acceptable model for further studies of the pharmacokinetics of amsacrine and its analogs, at doses .ltoreq. 5 mg/kg.This publication has 5 references indexed in Scilit:
- Volume Shifts and Protein Binding Estimates using Equilibrium Dialysis: Application to Prednisolone Binding in HumansJournal of Pharmaceutical Sciences, 1983
- High-performance liquid chromatographic method for the determination of 4′-(9-acridinylamino)methanesulfon-m-anisidide in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- IDENTIFICATION OF THE PRINCIPAL BILIARY METABOLITE OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE IN RATS1982
- 4′-(9-Acridinylamino) Methanesulfon-m-Anisidide (AMSA): A New Drug Effective in the Treatment of Adult Acute LeukemiaAnnals of Internal Medicine, 1980
- A fluorescence assay for 4′-(9-acridinylamino)methanesulfon-m-anisidide, a new antitumor agentAnalytical Biochemistry, 1979